NexPoint Real Estate Finance (NREF) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
15 Aug, 2026Executive summary
Net income attributable to common stockholders was $5.4 million, or $0.29 per diluted share, for Q2 2026, down from $0.54 in Q2 2025 and $0.42 in Q1 2026.
Earnings available for distribution (EAD) per diluted share rose to $0.46, up 7.0% year-over-year, and cash available for distribution (CAD) was $0.58 per share, flat quarter-over-quarter.
Portfolio reached $1.1 billion across 85 investments, with sector allocations led by life sciences (39.4%) and multifamily (37.6%).
Closed a $375 million drawable term loan facility, repaid $180 million in senior unsecured notes, and raised $22.6 million via Series C preferred shares.
Paid a $0.50 per share dividend for Q2 2026 and declared the same for Q3 2026.
Financial highlights
Book value per diluted share decreased 1.9% sequentially to $18.60, mainly due to unrealized losses in the stock loan portfolio.
Debt outstanding was $836.6 million with a weighted average cost of 6.3% and average maturity of 2.6 years.
Debt-to-equity ratio stood at 0.88x as of June 30, 2026.
Portfolio collateral is 80.3% stabilized, with a 63.4% loan-to-value and weighted average DSCR of 1.39x.
Implied dividend yield was 11.8% based on 2Q dividend annualized and share price as of August 5, 2026.
Outlook and guidance
Q3 2026 guidance: EAD expected at $0.435 per diluted share (range $0.38–$0.48), CAD at $0.555 per share (range $0.50–$0.60).
Estimated Q3 2026 net income attributable to common stockholders is $7.4 million–$9.8 million.
Board declared a $0.50 per share dividend for Q3 2026.
Management expects residential fundamentals to improve as supply declines and plans to redeploy capital from life science assets into residential.
Company intends to maintain regular quarterly dividends and meet REIT distribution requirements.
Latest events from NexPoint Real Estate Finance
- Q1 2026 net income was $10.0M ($0.42/share), with Q2 EAD guidance at $0.435 per share.NREF
Q1 2026 - Annual meeting to vote on directors, executive pay, auditor, and Series C stock issuance.NREF
Proxy filing - Annual meeting to vote on directors, compensation, auditor, and share issuance proposals.NREF
Proxy filing - Annual meeting to vote on directors, executive pay, auditor, and Series C stock issuance.NREF
Proxy filing - Q4 2025 net income was $13.6M, with Q1 2026 EAD per share guidance at $0.405.NREF
Q4 2025 - Q3 2025 net income surged, book value rose, and guidance signals stable earnings and dividends.NREF
Q3 2025 - Q2 net income was $7.5M, EAD/CAD per share rose, and $77.8M Series B was raised.NREF
Q2 2024 - Q3 2024 net income was $16.1M, with strong growth and stable Q4 guidance.NREF
Q3 2024 - Q1 2025 net income reached $16.5M ($0.70/share) with a diversified $1.2B portfolio and stable outlook.NREF
Q1 2025